3 ms·
Administering a vaccine that is only effective in young healthy people to young healthy people makes everyone safer. And that's the bad outcome where the slowe
by maxerickson 6y ago
Administering a vaccine that is only effective in young healthy people to young healthy people makes everyone safer.
And that's the bad outcome where the slower trials in more at risk people don't work out. In the good outcome, when you decide it is safe and effective in vulnerable people, production and administration have already been scaled out.
(could study viral load in a challenge trial where you don't have to test thousands of uninfected people to find asymptomatic cases…)